A tobacco-free world: a call to action to phase out the sale of tobacco products by 2040
This precludes further conclusions on the metabolic fate of 11-OHP4 in the context of cannabis use
Analytical approach First, we compared levels of psychological distress and sociodemographic covariates by frequency of vaping (every day, some days, ever but no longer, and never) using chi-squared tests to determine significance of omnibus differences across all categories
The current standard for drug-sensitive TB (DS-TB) is a 6-month regimen comprising isoniazid (INH), rifampin (also known as rifampicin) (RIF), pyrazinamide (PZA), and ethambutol (EMB), starting with a 2-month intensive phase of all four drugs, followed by 4 months of INH and RIF (Nyangwa et al., 2022), led to the introduction of 69 months regimens of bedaquiline, pretomanid, linezolid, with or without moxifloxacin (BPaL-M or BPaL, respectively), offering improved outcomes compared to older treatment strategies ( On this ground the WHO updated its DR-TB treatment guidelines in 2022 (WHO Consolidated Guidelines on Tuberculosis, 2024), recommending the 6-month BPaL-M regimen for MDR/Rifampicin-Resistant (RR)-TB in patients unexposed to bedaquiline, pretomanid, or linezolid (Vanino et al., 2023)
We have not recovered
